References
- Banchereau J., de Paoli P., Vallé A., Garcia E., Rousset F. Long term human B cell lines dependent on Interleukin 4 and anti-CD40. Science 1991; 251: 70–72
- Caligaris-Cappio F., Gobbi M., Bofill M., Janossy G. Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia. J. Exp. Med. 1982; 155: 623–627
- Clark E. A., Ledbetter J. A. Structure, function, and genetics of human B cell-associated surface molecules. Adv. Cancer Res. 1989; 52: 81–149
- Wetzel G. D. Interleukin 5 regulation of peritoneal Ly-1 B lymphocyte proliferation, differentiation and autoantibody secretion. Eur. J. Immunol. 1989; 19: 1701–1707
- Hayakawa K., Hardy R. R. Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage?. Ann. Rev. Immunol. 1988; 6: 197–218
- Sarfati M., Fournier S., Christoffersen M., Biron G. Expression of CD23 antigen and its regulation by Interleukin 4 in chronic lymphocytic leukemia. Leuk. Res. 1990; 14: 47–55
- Galanaud P., Karray S., Llorente L. Regulatory effects of IL-4 on human B-cell response to IL-2. Eur. Cytokine Net. 1990; 1: 57–64
- Defrance T., Banchereau J. Role of cytokines in the ontogeny, activation and proliferation of B lymphocytes. Cytokines and B. lymphocytes, R. Callard. Academic Press, London 1990; 65–114
- Defrance T., Vanbervliet B., Aubry J. P., Banchereau J. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2. J. Exp. Med. 1988; 168: 1321–1337
- Jelinek D. F., Lipsky P. E. Inhibitory influence of IL-4 on human B cell responsiveness. J. Immunol. 1988; 141: 164–173
- Llorente L., Crevon M. L., Karray S., Defrance T., Banchereau J., Galanaud P. Interleukin (IL) 4 counteracts the helper effect of IL-2 on antigen-activated human B cells. Eur. J. Immunol. 1989; 19: 765–769
- Karray S., Defrance T., Merle-Béral H., Banchereau J., Debré P., Galanaud P. Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells. J. Exp. Med. 1988; 168: 85–94
- Mallett S., Fossum S., Barclay A. N. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes—a molecule related to nerve growth factor receptor. EMBO J. 1990; 9: 1063–1068
- Tepper R. I., Pattengale P. K., Leder P. Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 1989; 57: 503–512
- Hivroz C., Gény B., Brouet J. C., Grillot-Courvalin C. Altered signal transduction secondary to surface IgM Cross-linking on B-chronic lymphocytic leukemia cells. J. Immunol. 1990; 144: 2351–2358
- Uckun F. M., Gajil-Peczalska K., Myers D. E., Jaszcz W., Haissig S. J. A. L. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 1990; 76: 2449–2456
- Bertoli L. F., Kubagawa H., Borzillo G. V., Burrows P. D., Schreeder M. T., Carroll A. J., Cooper M. D. Bone marrow origin of a B-cell lymphoma. Blood 1988; 72: 94–101